FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer By Ogkologos - January 17, 2025 649 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA2-mutated Metastatic Castration-Sensitive Prostate Cancer The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer MOST POPULAR Anal Cancer Advances Open Door to Screening and Prevention June 7, 2024 Partnering with Small Business to Advance Innovation in Cancer Research and... February 21, 2019 The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights... December 22, 2025 Talking About Sexual Health Concerns With Your Cancer Care Team: How... September 29, 2022 Load more HOT NEWS Making Cancer Clinical Trials Available to More Patients Medicare Open Enrollment is Here! How a Simple Tool Is Saving Lives of Children with Cancer... A toolkit to address disparities in digitally enabled oncology trials
